To evaluate HSP90 levels in situ, we performed tissue immunofluorescence in four experimental brain metastasis models from both human and mouse origin, characterized by different oncogenic drivers and derived from breast cancer, lung cancer, and melanoma, which are the most frequent sources of brain metastasis (Valiente et al, 2020). Here, HSP90AA1 is linked to breast carcinoma.